🕵️ Oramed Pharmaceuticals Inc. ($ORMP)
SEC insider & ownership activity, last 12 months · CIK 1176309 · every row links its SEC filing
Over the last 12 months insiders sold $942K with no open-market buying against it. Hexter Joshua sold $611K in discretionary trades (Jul). No red-flag 8-Ks in the window.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
0 buyers, $0 (0 lots) · 2 sellers, $942K (2 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Hexter Joshua | 0 | – | 1 | $611K | Jul 1, 2026 |
| Gabay Avraham | 0 | – | 1 | $331K | Jul 1, 2026 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Nadav Kidron | 7.6% | 13D | Feb 11, 2025 | filing ↗ | |
| BML Investment Partners, L.P. | 6.5% | 13G | Feb 13, 2025 | filing ↗ | |
| Aquamarine Financial (CAYMAN) Ltd | 5.1% | 13G | May 15, 2026 | filing ↗ | |
| Leonard Braden Michael | exited | 13G | Jun 29, 2026 | filing ↗ | |
| BML Investment Partners, L.P. | exited | 13G | Jun 29, 2026 | filing ↗ |
Planned insider sales (Form 144)
| Seller | Planned | Approx. sale date | |
|---|---|---|---|
| Hexter Joshua | $659K | Jul 1, 2026 | filing ↗ |
| Gabay Avraham | $449K | Jul 1, 2026 | filing ↗ |
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Charter/bylaw changes (5.03) | Jun 25, 2026 | filing ↗ |
| Other events (8.01) | Jun 25, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 25, 2026 | filing ↗ |
| Material agreement (1.01) | Mar 25, 2026 | filing ↗ |
| Acquisition or disposition (2.01) | Mar 25, 2026 | filing ↗ |
| Material agreement (1.01) | Feb 19, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Feb 19, 2026 | filing ↗ |
| Material agreement (1.01) | Jan 12, 2026 | filing ↗ |
| Other events (8.01) | Jan 12, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jan 12, 2026 | filing ↗ |
| Other events (8.01) | Jan 7, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jan 7, 2026 | filing ↗ |
| Officer/director changes (5.02) | Dec 31, 2025 | filing ↗ |
| Other events (8.01) | Dec 30, 2025 | filing ↗ |
| Earnings (2.02) | Nov 17, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 17, 2025 | filing ↗ |
| Material agreement (1.01) | Nov 16, 2025 | filing ↗ |
| Material Modifications to Rights of Security Holders (3.03) | Nov 16, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 16, 2025 | filing ↗ |
| Material agreement (1.01) | Oct 20, 2025 | filing ↗ |
| Agreement terminated (1.02) | Oct 20, 2025 | filing ↗ |
| Earnings (2.02) | Oct 20, 2025 | filing ↗ |
| Other events (8.01) | Oct 20, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Oct 20, 2025 | filing ↗ |
| Other events (8.01) | Sep 30, 2025 | filing ↗ |
| Officer/director changes (5.02) | Aug 19, 2025 | filing ↗ |
| Shareholder vote (5.07) | Aug 19, 2025 | filing ↗ |